Cryptosporidiosis in Ruminants: Update and Current Therapeutic Approaches
Ceren Dinler1 & Bulent Ulutas1 Show affiliations
- Adnan Menderes University, Turkey
American Journal of Animal and Veterinary Sciences, Volume 12, Issue 3, pp. 96–103 · doi.org/10.3844/ajavsp.2017.96.103
Abstract
Cryptosporidium species causes asymptomatic or mild to severe gastrointestinal disease in their broad range of host species. These host species include humans, domestic and wild animals worldwide. The importance of cryptosporidiosis in ruminants has been emphasised in recent years for not only mortality, delayed growth and economic losses in the farm but also zoonotic importance. So more than 200 substances have been tested against cryptosporidiosis, but none of them was able to eliminate the infection consistently. This article will focus on therapeutic interventions in neonatal ruminants against cryptosporidiosis including perspectives for new drugs.
Licence and reuse
Open access. This article is licensed under a Creative Commons Attribution 3.0 Licence (CC BY 3.0), as printed on the article, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original authors and the source. No permission is needed.
How to reuse this articleResponses (0)
About this article
Dinler, C. & Ulutas, B. (2017). Cryptosporidiosis in Ruminants: Update and Current Therapeutic Approaches. American Journal of Animal and Veterinary Sciences, 12(3), 96–103. https://doi.org/10.3844/ajavsp.2017.96.103
- Licence
- CC BY 3.0
- Issue
- Volume 12, Issue 3
- Policies
- Editorial independenceUse of generative AIData availabilityAppeals and complaints
- Version
- Version of record
